0:00
17:37
Jo Cheah chats with clinical pharmacologist Richard Day about off-label prescribing. Ric explains why off-label prescribing occurs, the barriers to getting new indications added to a drug’s approved label, and the potential risks of off-label prescribing without sufficient evidence. Read the full article by Richard Day in Australian Prescriber.
D'autres épisodes de "Australian Prescriber Podcast"
Ne ratez aucun épisode de “Australian Prescriber Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.